Efficacy and safety of modafinil in the treatment of cancer-related fatigue

Annals of Pharmacotherapy

Volumn 43, Issue 4, 2009, Pages 721-725

  Cooper, Maryann R ^a,b   Bird, Heather M ^c   Steinberg, Michael ^a  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c Rite Aid Pharmacy   (United States)

Author keywords

Cancer; Fatigue; Modafinil

Indexed keywords

ANTINEOPLASTIC AGENT; MODAFINIL; PLACEBO;

AGITATION; ANXIETY; ARTICLE; BACKACHE; BRAIN TUMOR; BREAST CANCER; CANCER FATIGUE; CANCER RADIOTHERAPY; CLINICAL TRIAL; COGNITION; CONSCIOUSNESS LEVEL; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; HUMAN; HUMAN RELATION; INSOMNIA; MOOD; MULTIPLE CYCLE TREATMENT; NAUSEA; NERVOUSNESS; NEUROSURGERY; PRIORITY JOURNAL; QUALITY OF LIFE; RHINITIS; SIDE EFFECT; SOMNOLENCE; TREATMENT REFUSAL; WALKING; WORK CAPACITY; XEROSTOMIA;

ANIMALS; BENZHYDRYL COMPOUNDS; FATIGUE; HUMANS; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 65749116600     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L532     Document Type: Article

References (19)

1. Morrow GR, Gillies LJ, Hickok JT, Roscoe JA, Padmanaban D, Griggs JJ. The positive effect of the psychostimulant modafinil on fatigue from cancer that persists after treatment is completed (abstract 8012). J Clin Oncol 2005;23:8012.
2. Carroll JK, Kohli S, Mustian KM, Roscoe JA, Morrow GR. Pharmacologic treatment of cancer-related fatigue. Oncologist 2007;12:43-51.
3. Winningham ML. Strategies for managing cancer-related fatigue syndrome: a rehabilitation approach. Cancer 2001;92:988-997 (Pubitemid 32781361)
4. Cella D, Davis K, Breitbart W, Curt G, Fatigue Coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001;19:3385-3391 (Pubitemid 32642191)
5. National Comprehensive Cancer Network. Cancer-related fatigue. www. nccn.org/professionals/physician-gls/PDF/fatigue.pdf (accessed 2008 Aug 8).
6. Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K. Management of cancer-related fatigue. Cancer Invest 2005;23:229-239 (Pubitemid 40770741)
7. Portenoy RK, Itri LM. Cancer-related fatigue: guidelines for evaluation and management. Oncologist 1999;4:1-10. (Pubitemid 29102450)
8. Burks TF. New agents for the treatment of cancer-related fatigue. Cancer 2001;92:1714-1718 (Pubitemid 32939180)
9. Product information. Provigil (modafinil). Frazer, PA: Cephalon Inc., March 2008.
10. Robertson P Jr, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet 2003;42:123-137 (Pubitemid 36188553)
11. Breitbart W, Alici-Evcimen Y. Update on psychotropic medications for cancer-related fatigue. J Natl Compr Canc Netw 2007;5:1081-1091 (Pubitemid 350247714)
12. Morrow GR, Jean-Pierre P, Roscoe JA, et al. A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: a URCC CCOP study (abstract 9512). J Clin Oncol 2008;26:9512.
13. Morrow GR, Ryan J, Kohli S, et al. Modafinil (Provigil) for persistent post-treatment fatigue: an open label study of 82 women with breast cancer (abstract 11-070). Support Care Cancer 2006;14:619.
14. Kaleita TA, Wellisch DK, Graham CA, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors (abstract 1503). J Clin Oncol 2006;24:1503.
15. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 1999;85:1186-1196
16. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-1123
17. Glaus A. Assessment of fatigue in cancer and non-cancer patients and in healthy individuals. Support Care Cancer 1993;1:305-315
18. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994;18(suppl):79S-83S. (Pubitemid 24023890)
19. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002;72:179-183 (Pubitemid 34102149)